Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.
Otero
M J
MJ
Fuertes
A
A
Sánchez
R
R
Luna
G
G
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008691:Methadone / Q000378:metabolism / Q000627:therapeutic use*; D009294:Narcotics / Q000378:metabolism / Q000627:therapeutic use; D019829:Nevirapine / Q000009:adverse effects*; D009293:Opioid-Related Disorders / Q000150:complications / Q000534:rehabilitation; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000534:rehabilitation; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
D019380:Anti-HIV Agents; D009294:Narcotics; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; D008691:Methadone